Stay updated on BBI608 Pembrolizumab Combination: Clinical Trial
Sign up to get notified when there's something new on the BBI608 Pembrolizumab Combination: Clinical Trial page.

Latest updates to the BBI608 Pembrolizumab Combination: Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3 tag; this reflects a minor site update rather than a change to the study details.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a maintenance patch to the study record page. No study data or user-facing content appears to have changed.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page revision tag was updated to v3.6.2, indicating a small version update. No substantive changes to study content are indicated.SummaryDifference0.1%

- Check46 days agoChange DetectedEnrollment status updated to indicate no longer recruiting; new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the revision history updated to v3.6.0, reflecting a formatting change to the Intervention/Treatment heading.SummaryDifference0.6%

- Check54 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a minor update to the page. No substantive study content appears to be affected.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a deployment update without visible changes to content or features.SummaryDifference0.1%

Stay in the know with updates to BBI608 Pembrolizumab Combination: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BBI608 Pembrolizumab Combination: Clinical Trial page.